We are live on
!
Find out more
MLL
Moody Lynn & Lieberson Portfolio holdings
AUM
$1.9B
1-Year Est. Return
27.82%
This Fund
S&P 500
This Quarter
Est. Return
+15.94%
1 Year Est. Return
+27.82%
3 Year Est. Return
+128.03%
5 Year Est. Return
+198.12%
10 Year Est. Return
+974.77%
AUM
$873M
AUM Growth
+$129M
(+17%)
Cap. Flow
+$29.7M
Cap. Flow
% of AUM
3.4%
Top 10 Holdings %
Top 10 Hldgs %
30.52%
Holding
204
New
16
Increased
60
Reduced
73
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$10.7M |
| 2 |
Salesforce
CRM
|
+$10.6M |
| 3 |
Paycom
PAYC
|
+$8.67M |
| 4 |
HealthEquity
HQY
|
+$7.6M |
| 5 |
Alibaba
BABA
|
+$7.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$8.66M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$7M |
| 3 |
Boston Scientific
BSX
|
+$5.64M |
| 4 |
Apple
AAPL
|
+$5.54M |
| 5 |
Merck
MRK
|
+$5.47M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.37% |
| 2 | Financials | 18.7% |
| 3 | Healthcare | 14.12% |
| 4 | Industrials | 10.57% |
| 5 | Consumer Staples | 6.64% |
Similar funds
EP
SIC
DCP
OPCM
FTCM
RCA
IAN
VC
Moody Lynn & Lieberson's Q1 2019 Portfolio in Review
As of Q1 2019, Moody Lynn & Lieberson held 204 positions worth $873M, up 17% from $744M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Moody Lynn & Lieberson deployed $29.7M of net new capital in Q1 2019, opening 16 new positions and adding to 60 existing holdings. Its largest new stake was HealthEquity: 108,043 shares worth $7.99M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Berkshire Hathaway Class B, an estimated $7M trimmed.
- Moody Lynn & Lieberson's largest Q1 2019 buy was HealthEquity: 108,043 shares worth $7.99M.
- Moody Lynn & Lieberson added most to Vanguard FTSE Emerging Markets ETF in Q1 2019, an estimated $10.7M increase.
- Moody Lynn & Lieberson's biggest Q1 2019 reduction was Berkshire Hathaway Class B, cutting an estimated $7M.
- Moody Lynn & Lieberson fully exited Amgen in Q1 2019, selling an estimated $8.66M.
- Moody Lynn & Lieberson's ten largest holdings make up 31% of its $873M portfolio in Q1 2019.
- Moody Lynn & Lieberson opened 16 new positions and closed 19 in Q1 2019.
- Moody Lynn & Lieberson's portfolio value rose 17% quarter-over-quarter to $873M.
Based on Moody Lynn & Lieberson's 13F filing for Q1 2019, filed 23 Apr 2019.